Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Barclays PLC Major Shareholding Notification 2021

Jun 11, 2021

5250_rns_2021-06-11_f604eaee-9e87-494c-a027-e89972e0abb8.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

Form 8.3 - WILLIS TOWERS WATSON PLC

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 10 June 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,880,806 1.46% 230,795 0.18%
(2) Derivatives (other than options):
72,359 0.06% 94,581 0.07%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
TOTAL:
1,959,265 1.52% 331,476 0.26%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

1. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit
Purchase 2 258.1200 USD
Purchase 7 256.2000 USD
Purchase 96 256.3458 USD
Purchase 100 256.5800 USD
Purchase 100 259.0800 USD
Purchase 100 259.1500 USD
Purchase 170 256.6664 USD
Purchase 380 257.9323 USD
Purchase 400 256.8695 USD
Purchase 621 258.0479 USD
Purchase 632 258.2614 USD
Purchase 1,425 258.0747 USD
Purchase 1,630 257.2892 USD
Purchase 2,088 258.2177 USD
Purchase 2,149 257.5000 USD
Purchase 3,324 257.4996 USD
Purchase 5,790 257.4454 USD
Purchase 9,601 258.8881 USD
Purchase 13,546 257.6854 USD
Purchase 14,050 258.0332 USD
Sale 9 257.7200 USD
Sale 18 257.8233 USD
Sale 55 257.3800 USD
Sale 70 257.9200 USD
Sale 100 258.3100 USD
Sale 100 257.3950 USD
Sale 155 257.9700 USD
Sale 162 257.7117 USD
Sale 200 257.3750 USD
Sale 300 257.8733 USD
Sale 400 256.8695 USD
Sale 550 258.1870 USD
Sale 580 258.2054 USD
Sale 601 257.3371 USD
Sale 649 258.0523 USD
Sale 869 257.3640 USD
Sale 1,040 257.3584 USD
Sale 1,346 257.3989 USD
Sale 1,407 258.0779 USD
Sale 1,549 257.5000 USD
Sale 1,991 256.8376 USD
Sale 2,009 257.2895 USD
Sale 2,024 257.4051 USD
Sale 3,324 257.4996 USD
Sale 3,343 257.9917 USD
Sale 4,158 257.5763 USD
Sale 4,349 257.7358 USD
Sale 11,853 258.0681 USD
Sale 13,000 258.7619 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit

(Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option
Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii) Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

(if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 (Open Positions) attached? YES
Date of disclosure: 11 Jun 2021
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210611005162/en/

BARCLAYS PLC